Ein Patientenleitfaden zu den neuesten klinischen Fortschritten bei neuen Therapien für rezidivierte/refraktäre chronische lymphatische Leukämie oder kleinzellige lymphatische Lymphome

Content Format:

PDF

Credit Type:

--

Credits:

--
Ein Patientenleitfaden zu den neuesten klinischen Fortschritten bei neuen Therapien für rezidivierte/refraktäre chronische lymphatische Leukämie oder kleinzellige lymphatische Lymphome

Content Format:

PDF

Credit Type:

--

Credits:

--
Ein Patientenleitfaden zu den neuesten klinischen Fortschritten bei neuen Therapien für rezidivierte/refraktäre chronische lymphatische Leukämie oder kleinzellige lymphatische Lymphome

Content Format:

PDF

Credit Type:

--

Credits:

--
Ein Patientenleitfaden zu den neuesten klinischen Fortschritten bei neuen Therapien für rezidivierte/refraktäre chronische lymphatische Leukämie oder kleinzellige lymphatische Lymphome

Content Format:

PDF

Credit Type:

--

Credits:

--
Ein Patientenleitfaden zu den neuesten klinischen Fortschritten bei neuen Therapien für rezidivierte/refraktäre chronische lymphatische Leukämie oder kleinzellige lymphatische Lymphome

Content Format:

PDF

Credit Type:

--

Credits:

--
Ein Patientenleitfaden zu den neuesten klinischen Fortschritten bei neuen Therapien für rezidivierte/refraktäre chronische lymphatische Leukämie oder kleinzellige lymphatische Lymphome

Content Format:

PDF

Credit Type:

--

Credits:

--
Germany – Regional Perspectives on the Management of Patients With R/R CLL/SLL

Content Format:

Slideset

Credit Type:

--

Credits:

--
Italy—Regional Perspectives on the Management of Patients With R/R CLL/SLL

Content Format:

Slideset

Credit Type:

--

Credits:

--
France—Regional Perspectives on the Management of Patients With R/R CLL/SLL

Content Format:

Slideset

Credit Type:

--

Credits:

--
US - Regional Perspectives on the Management of Patients With R/R CLL/SLL

Content Format:

Slideset

Credit Type:

--

Credits:

--
BTK Degrader Bexobrutideg in Patients With Relapsed/Refractory CLL/SLL  

Content Format:

Video

Credit Type:

AMA

Credits:

0.25
Second-line Pirtobrutinib in CLL/SLL After Covalent BTKi Treatment: A Pooled Analysis of BRUIN LOXO-BTK18001 and BRUIN CLL-321  

Content Format:

Video

Credit Type:

AMA

Credits:

0.25
CaDAnCe-101 Phase I Study of the BTK Degrader BGB-16673 in R/R CLL/SLL  

Content Format:

Video

Credit Type:

AMA

Credits:

0.25
BRUIN CLL-314: Pirtobrutinib vs Ibrutinib in Treatment-Naive and BTKi-Naive R/R CLL/SLL  

Content Format:

Video

Credit Type:

AMA

Credits:

0.25
Final Analysis of the Phase I/II BRUIN Trial of Pirtobrutinib in Patients With CLL/SLL Previously Treated with a Covalent BTKi    

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

0.25
ALPINE Long-term Extension Study of Zanubrutinib in Relapsed or Refractory CLL/SLL

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

0.25
From ASH 2025 to the Clinic: Global Perspectives on Evolving BTK Therapies in Relapsed/Refractory CLL

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.50
International Perspectives on Developments and Decision-making Tools for Frontline Treatment of CLL/SLL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Eine globale Initiative zur Verbesserung der Versorgung bei rezidivierter/refraktärer CLL

Content Format:

PDF

Credit Type:

--

Credits:

--
Appel mondial à l'action pour améliorer les soins dans le traitement de la LLC récidivante ou réfractaire

Content Format:

PDF

Credit Type:

--

Credits:

--
Una iniziativa internazionale per migliorare la cura della LLC recidivata/refrattaria

Content Format:

PDF

Credit Type:

--

Credits:

--
Llamamiento a la acción para mejorar resultados en el manejo de la leucemia linfocítica crónica (LLC) recidivante/refractaria al tratamiento oncológico  

Content Format:

PDF

Credit Type:

--

Credits:

--
Global Guide to First-line Treatment for CLL/SLL

Content Format:

Slideset

Credit Type:

--

Credits:

--
On the Frontlines of CLL/SLL: International Perspectives on First-line Treatments for CLL/SLL

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
A Global Call to Action for Advancing Care in Relapsed/Refractory CLL 

Content Format:

Clinical Thought

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.25
Interactive Tool for the Frontline Treatment of CLL: An International Expert Perspective

Content Format:

Tool

Credit Type:

--

Credits:

--
Interactive Tool With Expert Guidance for the Treatment of CLL: An International Perspective

Content Format:

Tool

Credit Type:

--

Credits:

--
Global Guide to BTK Inhibitor Treatment Decisions and AE Management in CLL 

Content Format:

Slideset

Credit Type:

--

Credits:

--
Global Perspectives and Clinical Resources to Guide Treatment Decisions and Management of Adverse Events With BTK Inhibitor Therapy in CLL 

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Interactive Tool to Guide Management of Adverse Events With BTK Inhibitor Therapy in Hematologic Malignancies

Content Format:

Tool

Credit Type:

--

Credits:

--
Expert Guidance for the Treatment of CLL: An International Perspective

Content Format:

Tool

Credit Type:

--

Credits:

--
A Year in Review: Expert Perspectives on Current and Emerging Data With BTK Inhibitors for CLL and MCL

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.50
A Year in Review and a Look to the Future: BTKi in CLL and MCL

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Interactive Tool for Managing BTK Inhibitor−Associated AEs in Hematologic Malignancies: A Global Perspective

Content Format:

Tool

Credit Type:

--

Credits:

--
Expert Guidance for the Treatment of CLL: An International Perspective

Content Format:

Tool

Credit Type:

--

Credits:

--
BTK Inhibitor Therapy for CLL: An International Perspective

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--